34.88USD+1.16%Mkt Cap: 1.28B USDP/E: —Last update: 2026-06-01
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segment…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap1.28B USD
Enterprise Value1.52B USD
Revenue (TTM)268.68M USD
Gross Profit204.37M USD
Net Income (TTM)-5.14M USD
Revenue/Share7.240 USD
Last Price34.88 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees373
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)13.15
PEG—
EV/EBITDA39.03
EV/Revenue5.65
P/S4.88
P/B45.73
EPS (TTM)-0.38
EPS (Forward)2.68
52W Range
26.8729% of range54.85
52W High54.85 USD
52W Low26.87 USD
Profitability
Gross Margin75.05%
Oper. Margin-49.95%
EBITDA Margin14.47%
Profit Margin-1.89%
ROE-9.80%
ROA-1.29%
Growth
Revenue Growth-7.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF43.86M USD
CapEx (TTM)1.10M USD
FCF Margin-1.88%
FCF Yield-0.39%
Net Debt204.69M USD
Net Debt/EBITDA5.27
Balance Sheet
Debt/Equity4.80
Current Ratio2.48
Quick Ratio2.16
Book Value/Sh0.7700 USD
Cash/Share2.575 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateFeb 8, 2013
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)67.75 USD
Target Range59.00 USD – 88.00 USD
# Analysts8
Ownership
Shares Out.37.28M
Float28.28M
Insiders15.47%
Institutions58.90%
Short Interest
Short Ratio7.3d
Short % Float19.40%
Short % Out.17.42%
Shares Short6.49M
Short (prev mo.)6.41M
Technical
SMA 5036.27 (-3.8%)
SMA 20041.34 (-15.6%)
Beta0.34
S&P 52W Chg27.94%
Avg Vol (30d)837.44K
Avg Vol (10d)870.63K
Technical Indicators
RSI (14)47.6
MACD-1.1307
MACD Signal-1.4724
MACD Hist.+0.3417
BB Upper42.84 USD
BB Middle34.73 USD
BB Lower26.63 USD
BB Width46.67%
ATR (14)1.934 USD
Vol Ratio (20d)0.61x